Skip to main content

Table 1 The expression of UGP2 and CFL1 in PDC, PT, BL, as well as NT, and their significance

From: Expression of UGP2 and CFL1 expression levels in benign and malignant pancreatic lesions and their clinicopathological significance

Type

Cases

UGP2 positive (%)

CFL1 positive (%)

PDC

106

62 (58.5)

56 (52.8)

PT

35

10 (28.6)**

9 (25.7)**

BL

55

11 (20.0)**

12 (21.8)**

NT

13

0 (0.0)**

0 (0.0)**

  1. Compared with PDC: **P < 0.01
Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us